Dataset Information


Detection of severity in Alzheimer's disease (AD) using computational modeling.

ABSTRACT: The prevalent cause of dementia - Alzheimer's disease (AD) is characterized by an early cholinergic deficit that is in part responsible for the cognitive deficits (especially memory and attention defects). Prolonged AD leads to moderate-to-severe AD, which is one of the leading causes of death. Placebo-controlled, randomized clinical trials have shown significant effects of Acetyl cholin esterase inhibitors (ChEIs) on function, cognition, activities of daily living (ADL) and behavioral symptoms in patients. Studies have shown comparable effects for ChEIs in patients with moderate-to-severe or mild AD. Setting a fixed measurement (e.g. a Mini-Mental State Examination score, as a 'when to stop treatment limit) for the disease is not clinically rational. Detection of changed regional cerebral blood flow in mild cognitive impairment and early AD by perfusion-weighted magnetic resonance imaging has been a challenge. The utility of perfusion-weighted magnetic resonance imaging (PW-MRI) for detecting changes in regional cerebral blood flow (rCBF) in patients with mild cognitive impairment (MCI) and early AD was evaluated. We describe a computer aided prediction model to determine the severity of AD using known data in literature. We designed an automated system for the determination of AD severity. It is used to predict the clinical cases and conditions with disagreements from specialist. The model described is useful in clinical practice to validate diagnosis.


PROVIDER: S-EPMC6077821 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3259850 | BioStudies
2019-01-01 | S-EPMC6447192 | BioStudies
2018-01-01 | S-EPMC6748330 | BioStudies
2010-01-01 | S-EPMC2843795 | BioStudies
2017-01-01 | S-EPMC5594223 | BioStudies
2019-01-01 | S-EPMC6865742 | BioStudies
2012-01-01 | S-EPMC3589736 | BioStudies
1000-01-01 | S-EPMC5696255 | BioStudies
1000-01-01 | S-EPMC3853114 | BioStudies
2019-01-01 | S-EPMC6542289 | BioStudies